Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MAZE | Maze Therapeutics, Inc. | Jan 30, 2025 | 0 | $0 | 3 | Jan 30, 2025 | Director |
ME | 23andMe Holding Co. | Aug 26, 2024 | 1 | $0 | 4 | Aug 28, 2024 | Director |
ALEC | Alector, Inc. | Aug 22, 2024 | 1 | -$228K | 4 | Aug 23, 2024 | Director |
ALEC | Alector, Inc. | Aug 2, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Director |
ALEC | Alector, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
ME | 23andMe Holding Co. | Sep 6, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
DICE | DICE Therapeutics, Inc. | Aug 9, 2023 | 6 | $0 | 4 | Aug 9, 2023 | Director |
ALEC | Alector, Inc. | Jul 15, 2023 | 1 | $0 | 4 | Feb 14, 2024 | Director |
ALEC | Alector, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
DICE | DICE Therapeutics, Inc. | May 5, 2023 | 1 | -$3.24M | 4 | May 9, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 16, 2023 | 3 | -$16.5K | 4 | Feb 21, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Nov 16, 2022 | 3 | -$10.7K | 4 | Nov 18, 2022 | Director |
ME | 23andMe Holding Co. | Nov 11, 2022 | 1 | -$59.7K | 4 | Nov 14, 2022 | Director |
ME | 23andMe Holding Co. | Sep 6, 2022 | 1 | $0 | 4 | Sep 8, 2022 | Director |
ME | 23andMe Holding Co. | Aug 25, 2022 | 1 | $0 | 4 | Aug 29, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 16, 2022 | 3 | -$12.2K | 4 | Aug 18, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
ALEC | Alector, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
DICE | DICE Therapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | May 16, 2022 | 3 | -$8.83K | 4 | May 18, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 15, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Dec 2, 2021 | 2 | $0 | 4 | Dec 6, 2021 | Director |
DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 6 | $0 | 4 | Sep 16, 2021 | Director |
ME | 23andMe Holding Co. | Sep 14, 2021 | 1 | $0 | 4 | Sep 16, 2021 | Director |
DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 0 | $0 | 3 | Sep 14, 2021 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 4, 2021 | 3 | -$499K | 4 | Aug 6, 2021 | Title: Chairman of Research and Development, Director |
ALEC | Alector, Inc. | Jul 2, 2021 | 5 | -$1.3M | 4 | Aug 9, 2021 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Chairman of R&D, Director |
ALEC | Alector, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
ME | 23andMe Holding Co. | Jun 16, 2021 | 0 | $0 | 3 | Jun 25, 2021 | Director |
ORIC | Oric Pharmaceuticals, Inc. | May 20, 2021 | 3 | -$50K | 4 | May 24, 2021 | Director |
ORIC | Oric Pharmaceuticals, Inc. | May 14, 2021 | 3 | -$201K | 4 | May 18, 2021 | Director |
ORIC | Oric Pharmaceuticals, Inc. | May 11, 2021 | 3 | -$12.6K | 4 | May 13, 2021 | Director |